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Objectives: The development of daptomycin resistance in Staphylococcus aureus is associated with clinical
treatment failures. The mechanism(s) of such resistance have not been clearly defined.
Methods: We studied an isogenic daptomycin-susceptible (DAPS) and daptomycin-resistant (DAPR) S. aureus
strain pair (616; 701) from a patient with relapsing endocarditis during daptomycin treatment, using compara-
tive transcriptomic and proteomic techniques.
Results: Minor differences in the genome content were found between strains by DNA hybridization. Transcrip-
tomic analyses identified a number of genes differentially expressed in important functional categories: cell div-
ision; metabolism of bacterial envelopes; and global regulation. Of note, the DAPR isolate exhibited reduced
expression of the major cell wall autolysis gene coincident with the up-regulation of genes involved in cell
wall teichoic acid production. Using quantitative (q)RT–PCR on the gene cadre putatively involved in cationic
peptide resistance, we formulated a putative regulatory network compatible with microarray data sets,
mainly implicating bacterial envelopes. Of interest, qRT–PCR of this same gene cadre from two distinct isogenic
DAPS/DAPR clinical strain pairs revealed evidence of other strain–dependent networks operative in the DAPR
phenotype. Comparative proteomics of 616 versus 701 revealed a differential abundance of proteins in
various functional categories, including cell wall-associated targets and biofilm formation proteins. Phenotypi-
cally, strains 616 and 701 showed major differences in their ability to develop bacterial biofilms in the presence
of the antibacterial lipid, oleic acid.
Conclusions: Compatible with previous in vitro observations, in vivo-acquired DAPR in S. aureus is a complex,
multistep phenomenon involving: (i) strain-dependent phenotypes; (ii) transcriptome adaptation; and
(iii) modification of the lipid and protein contents of cellular envelopes.
Keywords: cell wall metabolism, antibiotic resistance, biofilms, d-haemolysis, oleic acid, microarrays, virulence, quantitative
proteomics
Introduction
Daptomycin (formerly LY146032) is a cyclic lipopeptide antimi-
crobial that was recently approved in the USA for the treatment
of a wide variety of Staphylococcus aureus infections [both
methicillin-susceptible S. aureus (MSSA) and methicillin-resistant
S. aureus (MRSA)], including skin and soft tissue infections,
uncomplicated bacteraemia and right-sided endocarditis.1 In
vitro, this agent is rapidly bactericidal against S. aureus in a
concentration-dependent manner.2,3 However, clinical treatment
failures due to the emergence of daptomycin-resistant (DAPR)
strains during therapy have now been described, especially in
subacute and chronic infections such as osteomyelitis and
endocarditis, and with prolonged daptomycin exposure.2,4
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Daptomycin absolutely requires Ca2+ for activity:5,6 while the
native molecule is anionic, daptomycin is less active microbiolo-
gically (10 times) until it is heavily calcium decorated, making
this agent a de facto cationic antimicrobial peptide functionally.7
To date, no specific genetic determinant(s) of DAPR in
S. aureus have been universally defined in such strains, despite
several well-known phenotypic correlates of DAPR [e.g. thickened
cell walls, enhanced surface charge, alterations in cell mem-
brane (CM) fluidity, cross-resistance to host defence cationic pep-
tides, altered CM phospholipid synthesis and/or translocations].8
Also, previous investigations by our group and others suggested
that alterations of CM fluidity may increase S. aureus resistance
to antibacterial lipids such as oleic acid,9 i.e. natural compounds
having structural characteristics similar to the lipid moiety of
daptomycin.10 Of note, CM modification in S. aureus appears to
affect the abilities of such strains to develop and maintain
bacterial biofilms.11,12 Importantly, resistance to glycopeptide
antibiotics such as vancomycin has been linked to a number
of phenotypic perturbations, including bacterial envelope
changes,13,14 the ability to produce biofilms15 and/or differences
in the cell wall peptidoglycan composition.16 Concomitantly, we
and others have confirmed that S. aureus DAPR acquired either
during serial in vitro passage or, more relevant to this investi-
gation, emerging during daptomycin therapy features a temporal
and progressive ‘accumulation’ of genetic polymorphisms [single
nucleotide polymorphisms (SNPs)].17 The acquisition of such
SNPs has been most commonly observed within the mprF and/
or yyc operons, with the former operon being important in
surface positive charge maintenance, and the latter operon
being a vital regulatory locus involved in CM lipid biosynthesis,
cell wall homeostasis and biofilm formation.18,19 Interestingly,
these SNPs have frequently been associated with genetic ‘gains
in function’.20,21
Although such studies have been pivotal in disclosing poten-
tial phenotypic and genotypic correlates of DAPR, the precise
interaction(s) among DAPR, CM lipid resistance, surface charge
and biofilm dynamics, as well as putative DAPR genetic ‘path-
ways’, remain to be elucidated. The overarching goal of the
current study was to gain new insights into putative genetic
determinants and pathways involved in the emergence of DAPR
in S. aureus in vivo. Thus, we undertook a combined transcrip-
tomic–proteomic–phenotypic correlate approach to attempt
further clarification of these issues.17
Materials and methods
Reagents and chemicals
All chemicals purchased were of the highest purity grade, unless other-
wise stated. LiChrosolv water (Merck, Darmstadt, Germany) was used
for the preparation of all buffers and solvents. Acetonitrile was purchased
from Biosolve (Westford, MA, USA). Trifluoroacetic acid (TFA),
a-cyano-4-hydroxycinnamic acid, 1,4-dithioerythritol, ammonium
bicarbonate, iodoacetamide, glycine, porcine trypsin, Tris, BSA, rabbit
phosphorylase b, chicken ovalbumin and bovine b-casein were from
Sigma–Aldrich (St Louis, MO, USA). Immobilized pH gradient (IPG) strips
and ampholines were purchased from GE Healthcare (Piscataway, NJ,
USA). SDS–PAGE pre-cast gels and molecular mass markers were
purchased from Bio-Rad (Hercules, CA, USA).
Bacterial strains and cultures
The two primary strains (methicillin susceptible) used in this study have
been described in detail previously.22 Strain 616 is the parental (pre-
therapy) daptomycin-susceptible (DAPS) bloodstream isolate initially
obtained from a patient with endocarditis [daptomycin MIC
(Etest)¼0.5 mg/L]; strain 701 is a DAPR organism recovered during dap-
tomycin treatment (daptomycin MIC¼2 mg/L) [although the currently
accepted terminology should be ‘daptomycin non-susceptibility’, ‘dapto-
mycin resistance’ (DAPR) is used in this manuscript for ease of presen-
tation]. These strains were isogenic by pulsogram as previously
detailed, and were each agr type 2.22 Lastly, strain 701 (but not 616) con-
tained an SNP within the mprF open reading frame (ORF) (S295L), which
resulted in a phenotypic ‘gain in function’ of the mprF gene as previously
described, localized to the putative ‘translocase’ domain for flipping lysyl-
phosphotidylglycerol from the inner CM to the outer CM.23,24 Moreover,
transmission electron microscopy (TEM) revealed this DAPR isolate to
have significantly thicker cell walls than the DAPS parental strain.25
For selected and strain-dependent comparisons [multiple loci variable
number tandem repeat analysis (MLVA) and quantitative (q)RT–PCR, see
below], two additional DAPS/DAPR S. aureus strain pairs were utilized. Both
strain pairs were obtained from patients with recalcitrant endocarditis;
the clinical, phenotypic and selected genotypic details of these isolate
pairs have been previously described.26,27 Both DAPS/DAPR strain pairs
were identical by PFGE pulsograms. They included MSSA strain pair
BOY755 and BOY300, and MRSA strain pair 11-11 and REF2145,
respectively.24
Biofilm assays
The potential impact of adaptations to daptomycin upon biofilm charac-
teristics was assessed. S. aureus strains were grown in trypticase soy
broth (TSB; Becton Dickinson, Le Pont de Claix, France) supplemented
with 1% (w/v) glucose. Oleic acid (cis-9-octadecenoic acid; Sigma–
Aldrich, Basel, Switzerland), used to mimic the lipid tail of daptomycin,
was emulsified with TSB–glucose media (TSBglucOleic) by overnight agi-
tation at 220 rpm in a Lab-Shaker at 378C. Biofilm development was per-
formed in TSBgluc (or TSBglucOleic emulsions) with 20 mL of overnight
culture/mL of fresh medium (6 mL). Bacterial colonies were counted on
Mueller–Hinton agar plates (MHA; Bio-Rad, Marnes-La-Coquette,
France). Biofilm staining assays were performed as described
previously.11
Bacterial counting methods
Direct counting was performed in Neubauer chambers, as previously
described.11 Determination of colony forming units was performed
on MHA using a Countermat Flash colony counter (IUL, RB Scientific,
Southampton, England).
Assessment of d-haemolysin activity
As will be demonstrated below, we identified differences in agr expression
(a key global regulon of S. aureus) between DAPS and DAPR strain pairs. To
assess the phenotypic correlates of this genotypic difference, the func-
tions of the agr operon were measured by d-haemolysin production.
The d-haemolytic activities were determined by first streaking RN4220,
a strain that only produces b–haemolysin, without the interference of
a- and d-haemolysins, on sheep blood agar plates.28 Then, the test
strains were streaked perpendicularly to the RN4220 streak. The b- and
d-haemolysins of S. aureus act synergistically in the lysis of sheep red
blood cells. Therefore, d-haemolysin produced by any test strain results
in a zone of enhanced haemolysis in areas where this haemolysin over-
laps with the b-haemolysin zone of the RN4220 strain. The degree of
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synergistic haemolysis was graded from 0 to 4+ by one of the authors
(S.-J. Y.), who was blinded as to the agr transcription data and strain iden-
tities.29 All experiments were conducted at least twice on separate days.
Genotyping of S. aureus strains by MLVA assay
The DAPS and DAPR isolate pairs (616 and 701, BOY755 and BOY300, and
MRSA11-11 and REF2145), previously characterized by PFGE, were
additionally genotyped using a well-described MLVA assay.30 This
method assesses genomic elements that are different to those deter-
mined by PFGE. This technique affords higher resolution than traditional
PFGE, as it is able to further discriminate into subclusters some isolates
that appear clonal by multilocus sequence typing (MLST).31 For clonal
cluster (CC) comparisons, we utilized the following strains with well-
characterized ‘clonal complex’ profiles: N315 and Mu50 (CC¼5); COL,
USA300 and NCTC 8325 (CC¼8); and MW2 and MSSA476 (CC¼1).
Transcriptional analyses
Microarray manufacturing and design
The microarray was manufactured by the in situ synthesis of 10807
60-mer long oligonucleotide probes (Agilent, Palo Alto, CA, USA), selected
as previously described.32 It covers.98% of all ORFs annotated in strains
N315 and Mu50,33 MW234 and COL,35 NCTC 8325 and USA300,36 as well
as MRSA252 and MSSA476 (including their respective plasmids).37
Preparation of labelled nucleic acids for expression
microarrays
Total RNA was purified from both early and late exponential phase bac-
teria grown in Mueller Hinton broth (MHB) and treated with DNase. Prep-
arations of 5 mg of total S. aureus RNA were labelled with Cy-3 dCTP using
the SuperScript II method (Invitrogen, Basel, Switzerland) and purified, as
previously described.38
Purified genomic DNA from the reference sequenced strains used
for the design of the microarray was labelled with Cy-5 dCTP and
used in microarray normalization.39 Mixtures of Cy5-labelled DNA and
Cy3-labelled cDNA were hybridized and scanned, as previously
described.38
Microarray analysis
Hybridization fluorescence intensities were quantified using Feature
Extraction software (Agilent, version 8). Local background subtracted
signals were corrected for unequal dye incorporation or unequal load
of the labelled product, using a rank consistency filter and a curve-fitting
algorithm per the default LOWESS (locally weighted linear regression)
method. Data from three independent biological experiments were ana-
lysed using GeneSpring 8.0 (Silicon Genetics, Redwood City, CA, USA), as
previously described,38 with a 5% false discovery rate (P value cut-off,
0.05) and an arbitrary threshold of 1.5-fold for defining significant differ-
ences in expression ratios. The complete microarray data set is posted on
the Gene Expression Omnibus database, available at http://www.ncbi.
nlm.nih.gov/geo/, under accession numbers GPL7137 for the platform
design and GSE28632 for the original data set.
Real-time PCR (qRT–PCR) validation
Gene-specific probes were designed using Primer Express 3.0 (Applied
Biosystems) and are shown in Table 1. Oligonucleotide primers and
probes obtained from Sigma or Applied Biosystems (minor groove
binder coupled to dark quencher) were solubilized in water, and reactions
were assembled in a one-step RT–PCR enzymatic mixture (Invitrogen,
Carlsbad, Germany) in a final volume of 10 mL. Reactions were performed
in a StepOne Plus instrument (Applied Biosystems), as described pre-
viously.40 Results were normalized using intensity levels recorded for
the rRNA 16S gene, as described previously.41 These studies provided
relative gene expression for DAPR strains 701, BOY300 and REF2145 as
compared with their respective parental DAPS isolates listed above. The
statistical significance of strain-specific differences in the normalized
cycle threshold values for each transcript was evaluated by the paired
t-test, and data were considered significant at P values ,0.05.
Proteomics analyses
The complete procedure is described by Vaezzadeh et al.42 Adaptations in
the methods or experimental design for the current study are described
below.
S. aureus strain growth conditions
Bacterial strains were grown in MHB, essentially as described previously.38
Cells were grown for 5 h and lysed with 20 mg/L lysostaphin (Ambicin;
Applied Microbiology, Tarratown, NY, USA) for 15 min at 378C, in Tris–
EDTA buffer. For preparation of crude membrane extracts, 20 mL
culture aliquots were washed in 1.1 M saccharose-containing buffer
and then suspended in 2 mL aliquots of the same buffer containing
50 mg/L of the hydrolytic enzyme lysostaphin for 10 min at 378C. Proto-
plasts were recovered after centrifugation (30 min at 8000 g) and mem-
brane pellets were obtained after ultracentrifugation at 50000 g for
50 min.
Sample preparation
Quantitative mass spectrometry-based proteomic experiments were per-
formed on three independent replicates. Samples were prepared using
isobaric tags iTRAQ (Applied Biosystems, Framingham, MD, USA), accord-
ing to the manufacturer’s protocol. Digestion was performed by trypsin at
a protease-to-protein ratio of 1:25 using microwave catalysis (FUNAI,
Hamburg, Germany). After digestion, the reaction was immediately
quenched with 1 M formic acid.42 For Experiment 1 (PR1), strain 616
was labelled with iTRAQ 114 and 701 with iTRAQ 117. For Experiment
2 (PR2), strain tags were crossed; strain 616 was labelled with iTRAQ
117 and 701 with iTRAQ 116. Lastly, for Experiment 3 (PR3), strain 616
was labelled with iTRAQ 116 and 701 with iTRAQ 114.
IPG-isoelectric focusing (IEF)
IPG-IEF was performed under the following conditions, in sequence: (i) an
initial 30 min step at 500 V; (ii) a linear gradient from 500 V to 4 kV over
90 min; (iii) a linear gradient from 4 kV to 8 kV in 30 min; and (iv) a final
step-up cycle from 8 kV to 30 kV for 30 min. Samples (200 mL) were
loaded by overnight in-gel rehydration. Next, IPG strips were washed
three times for 10 s each in three distinct high-boiling point petroleum
ether baths to remove the paraffin oil. Each strip was then manually
cut and gel pieces were placed in polypropylene tubes containing 80 mL
of 0.1% TFA. After three separate 30 min incubations with 0.1% TFA, all
extracts were pooled. The samples were then cleaned using an Oasis
HLB m-Elution 96-Well Plate system as per the manufacturer’s protocol
(Waters, USA). Purified samples were then dried by evaporation, resus-
pended in 25 mL HPLC buffer A (0.1% formic acid in 3% acetonitrile)
and stored at 2208C.
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Liquid chromatography–mass spectrometry (LC–MS)
and peptide analysis
A 5 mL peptide solution of each fraction was loaded in a 10 cm long
column with an internal diameter of 100 mm. The elution gradient
from 4% to 38% of the counter solvent (0.1% formic acid in 80% aceto-
nitrile) was developed over 40 min and samples were eluted directly on a
matrix-assisted laser desorption/ionization (MALDI) target using a spot-
ting robot. An aqueous solution of matrix [a-cyano-4-hydroxycinnamic
acid; 5 mg/mL (w/v) in 50% acetonitrile/0.1% TFA/10 mM NH4H2PO4]
was applied and dried. Peptides were analysed in MS and MS/MS
modes using a 4800 MALDI–time of flight (TOF)/TOF tandem mass spec-
trometer (Applied Biosystems) using a neodymium-doped yttrium alu-
minium garnet (Nd:YAG) laser at 355 nm, operating at 200 Hz. Eight
hundred and 1500 consecutive laser desorptions were accumulated for
MS and MS/MS spectra, respectively. Data-dependent MS/MS analysis
was performed automatically on the 15 most intense ions from MS
spectra, with lysozyme C as the external control.
Protein identification
Peak lists were generated from raw data using the PeaktoMascot soft-
ware, as appropriate to the instrument. The combined peak lists of all
fractions of the same IPG strip were merged into a single mascot
generic file (mgf) format and searched against a database containing
the 2581 genome-sequenced S. aureus strain N315 proteins (UniProt
knowledgebase; release 15.12, 15 December 2009) using Phenyx
(GeneBio, Geneva, Switzerland) with parent ion tolerance set to
100 ppm. A variable amino acid modification was oxidized methionine.
Trypsin was selected as the enzyme, with one potential missed cleavage,
and the normal cleavage mode was used. The peptide p value was
1×1022 for linear ion trap-orbitrap data. False-positive ratios were esti-
mated using a reverse decoy database.43 All data sets where searched
once in the forward and once in the reverse database. Separate searches
were used to keep the database size constant. Protein and peptide scores
were then optimized to maintain a false-positive ratio ,1%, biasing
toward a conservative slight overestimation of the false-positive ratio.43
For all analyses, only proteins matching two different peptide sequences
were prioritized for further consideration.
Data analysis using iTRAQ quantification
Reporter-ion abundances for each identified peptide were quantified
directly from peak lists using the dedicated Phenyx export. Extracted
ion abundance values were corrected from isotopic impurities44,45 and
relative peptide ratios calculated by the quotient of corrected reporter-ion
Table 1. List of primers/probes for qRT–PCR
Primer/probe name Sequence (5′3′) Dye/quencher Length (bp) Cf (mM) NCBI accession no.
asp23_299_F GTTAAGCCACCTTTCATGTCTAAGATAC 28 0.2
asp23_390_R AAATTAACTTTCTCTGATGAAGTTGTTGA 29 0.2 NP_375295.1
asp23_333_T CTTCACGTGCAGCGATACCAGCAATTT FAM/TAMRA 27 0.1
mprF_F TCATTGCTGCATTATCAGGTTTAGTC 28 0.2
mprF_R TTCCTCAGGGACACCTAAAGTTTT 29 0.2 NP_374473.1
mprF_P ATTCCTGGTGGTTTCGGCG FAM/3BQ1 27 0.1
hla_337_F ATGAGTACTTTAACTTATGGATTCAACGG 28 0.2
hla_437_R AGTGTATGACCAATCGAAACATTTG 29 0.2 M90536.1
hla_385_T ACAGGAAAAATTGGCGGCCTTATTGGT FAM/MGB 27 0.1
rot_332_F GAGTTAATGTCACCCAAAAGTGTTTCT 28 0.2
rot_418_R TTGGGAGATGTTTAGCATGAAAAA 29 0.2 NP_374872.1
rot_MGB CAAAATTCCAAATACAGTGTCGTT FAM/MGB 27 0.1
saeRS_F AAGAACATGATACCATTTACGCCTTA 28 0.2
saeRS_R CCTTGGACTAAATGGTTTTTTGACA 29 0.2 NP_373916.1
saeRS_P CTTTAGGTGCAGATGACT FAM/MGB 27 0.1
sarA_17_F ACATGGCAATTACAAAAATCAATGAT 28 0.2
sarA_167_R TCTTTCTCTTTGTTTTCGCTGATG 29 0.2 NP_373827.1
sarA_45_T CTTTGAGTTGTTATCAATGGT FAM/MGB 27 0.1
sarR_F TGAGTCTAACGAAATCTCATCTAAAGAGA 28 0.2
sarR_R CAATAACTGTTCTTTCGTCTTGTAAACTTC 29 0.2 NP_375408.1
sarR_P TGCTAAGTGCTCAGAGTT FAM/MGB 27 0.1
sarS_552-576_F CCACCATAAATACCCTCAAACTGTT 28 0.2
sarS_615-638_R TCATCTTCAGTTGAGCGTTCTTTT 29 0.2 NP_373349.1
sarS_595-613_P AAAAAGCAAGGCTATCTAA FAM/MGB 27 0.1
sarT_217-241_F AGCGTAAAAGAATTATCAAAAAAGG 28 0.2
sarT_306-280_R TTTTACAGAAACAACAATGATTACATT 29 0.2 NP_375610.1
sarT_243-265_P TTACTTGAATAAATGTAGAGACC FAM/MGB 27 0.1
mprF, fmtC; sarS, sarH1; Cf, final concentration; NCBI, National Center for Biotechnology Information.
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abundances at an m/z ratio corresponding to the respective channels.
Protein ratios were then obtained by calculating the geometric mean of
all peptide ratios corresponding to a given protein.
Results
DAPR and biofilm formation
A first step in studying the potential in vivo characteristics of
S. aureus DAPR was to investigate the potential correlation
between this resistance phenotype and biofilm formation.
S. aureus strains 616 (DAPS) and 701 (DAPR) were exposed to
0.1% oleic acid in microtitre plates in a biofilm assessment
assay.11 We chose oleic acid because of its similar biochemical
nature to the lipid tail of daptomycin, in which the first seven
carbene groups (CH2) are similar to the first eight carbene
groups (CH2) of the daptomycin lipid tail, following the methyl
terminal group in each molecule.
In the presence of oleic acid in the nutrient medium during
growth inplanktonic suspension, parental strain616cells outnum-
bered DAPR 701 cells (Figure 1a and b). Both isolates produced an
abundant biofilm in oleic acid-free conditions on polystyrene
plates (Figure 1c). The total amount of biofilm assessed after solu-
bilization of crystal violet appears similar for the two strains
(Figure 1d). However, in the presence of oleic acid, the adherent
bacterial population appeared significantly larger in the DAPR
strain than in the DAPS strain (Figure 1d). Consequently, the pro-
portion of bacteria in suspension appears larger for strain 616
than for strain 701, indicating an abundant release of adherent
bacteria (Figure 1a and b). We also observed a totally different
biofilm organization between the two isolates: while strain 616
showed a homogeneous colonization of the surface, strain 701
demonstrated large macroscopic aggregates (Figure 1c).
agr function
As shown in Figure S1 (available as Supplementary data at JAC
Online), for the 616 versus 701 comparisons, both strains elabo-
rated d-haemolysin, although the parental strain appeared to
produce somewhat more. In comparing BOY755 versus
BOY300, d-haemolysin production was equivalent. Of interest,
parental MRSA11-11 produced extensive d-haemolysin, while
DAPR REF2145 elaborated very little d-haemolysin.
Genotypic characterization of the isolate set
MLVA revealed that the three strain sets were strictly clonal, but
differed from each other in dendrogram analysis (data not
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Figure 1. Biofilms of strains 616 and 701 under oleic acid stress and bacterial quantification. (a) Serial dilutions of planktonic cells spotted on agar
plates. (b) Quantification of planktonic cells by OD540 for two independent experiments. (c) Biofilms stained with crystal violet in a 6-well multititre
plate. The box shows a magnification of strain 701 grown in the presence of oleic acid and the arrows show spots stained with crystal violet.
(d) Adherence in the presence of oleic acid during two independent experiments. Error bars show the range of duplicate experiments.
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shown). Further analyses of the genome content of strain 616
versus strain 701 showed that the two isolates belonged to
the same cluster and were most similar to the N315/Mu50
lineage.32,38 Note also that strains COL, USA300 and NCTC
8325, belonging to clonal complex 8, segregated into the same
cluster, as did the two CC1 isolates, MW2 and MSSA476
(Figure 2). Interestingly, the comparison of the 616–701 DAPS/
DAPR strain pair confirmed the acquisition of genes belonging
to pUSA300, underscoring the notion that genetic elements
may be acquired in vivo.36 However, on a more global basis,
the list of regions or probes showing divergence following ‘geno-
motyping’ analysis software (GACK)46 after hybridization of
genomic DNA revealed only a limited number of putative hits
when the strain pair isolates were compared. Our microarray
design allowed mapping of the S. aureus genome using an
average of one probe every 450 nucleotides (Table 2).
In addition, given the known major role of the global regulon,
agr, in staphylococcal virulence factor expression, biofilm
formation, persistent bacteraemia and glycopeptide resist-
ance,47–51 the entire agr locus was sequenced in the two princi-
pal study strains. Both isolates revealed agr locus sequences
identical to that of strain Mu3, i.e. with silent point mutations
in agrA (AG at position 264; data not shown).
Transcriptomic analysis
The results summarized in Table 3 were obtained from the
average values of three independent replicate experiments
showing at least a difference of +1.5-fold between the DAPS
and DAPR strains. In general, when comparing strain 616 with
strain 701, although often statistically significant, most of the
fold change values observed for the differentially expressed
genes were moderate (2–4-fold range). The total number of
genes showing differential expression at 5 h (late exponential
phase) was 120. For the majority of these genes, the trends
in differential expression seen at 5 h were also observed at 3 h
(early exponential phase; data not shown). Overall, among
these differentially expressed genes, 42% were up-regulated in
the DAPR strain as compared with the DAPS strain, while 58%
were down-regulated. Genes involved in metabolic functions
constituted nearly one-half (47%) of those differentially
expressed (e.g. sugar metabolism, such as lac A-B-D-E-F, or
amino acid metabolism, such as arcA-B-B1-B2-D or argF-H for
ornithine degradation and pH homeostasis). Among this cat-
egory of genes, 74% were up-regulated in the DAPR isolate as
compared with the DAPS isolate, whereas 26% showed the oppo-
site trend. In addition, 15% of the differentially regulated genes
belonged to gene families involved in the processes of translation
or transcription, with 38% down-regulated and 62%
up-regulated in the DAPR strain versus the DAPS strain. Cell wall
metabolism genes also appeared as an important category dis-
tinguishing the two strains, showing only up-regulated genes in
the DAPR isolate (n¼9/9). Genes that were ‘highly up-regulated’
(i.e. ≥5-fold) in the DAPR strain as compared with the DAPS strain
were observed in the following categories: (i) metabolic func-
tions, such as the tre and lac operons (.10-fold); (ii) putative
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Figure 2. Molecular genotyping of the set of strains. Genotyping tree obtained using microarray covering whole S. aureus genomes of eight sequenced
strains revealed thatour isolatesaregeneticallycomparablewhileN315appearsas themore related referencestrain. Eachprobe is representedbya single
row of grey-scaled boxes and each sample corresponds to a single column. The grey areas correspond to genes present, whereas white bars indicate
missing genes (N315 used as the reference). The dendrogram (top and left part of the figure) represents the similarity matrix of probe sets.
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virulence factors, such as the egc cluster encoding clinically
important enterotoxins (.5-fold), hlb (.6-fold) and von Willeb-
rand factor-binding protein (MW 766 kDa;.7-fold); and (iii) several
ABC transporters (.5-fold). Selected gene grouping differences are
further detailed below.
Metabolism and cell wall-related genes
The main categories of metabolic genes that were found to be
differentially regulated are involved in the transport of amino
acids, carbohydrates, coenzymes and lipids. The vast majority
of these genes belonged to amino acid metabolism and trans-
port families (e.g. arginine and ornithine metabolism), and
were generally down-regulated by 2–4-fold in the DAPR versus
DAPS strains. Of note, most of the lac operon appeared to be
up-regulated in the DAPR isolate.
Among the genes involved in the biogenesis of the bacterial cell
wall, some components of the lyt operon (e.g. lytN and lytH) were
up-regulated in DAPR versusDAPS isolates. The taggenes (tagAand
tagG) involved in the biogenesis and transport of teichoic acids
were found to be significantly up-regulated in the DAPR isolate. A
similar observation was noted for penicillin–binding proteins,
pbp2 and pbp4. Moreover, genes belonging to the yycG/yycF
operon (yycI and yycJ) were found to bemoderately up-regulated
in the DAPR strain. This systemhas been described as an important
regulator of virulence (through the alteration of ssaA and lytM
expression), as well as cell wall biosynthesis (through its action
on tagA-D expression) and biofilm production. Interestingly, yycG
has been linked to the DAPR phenotype in a recent report on
such mutants obtained from in vitro passages and also following
daptomycin exposure in vivo.52,53
Regulators and virulence factors
Numerous regulatory genes were found to be differentially
expressed between the DAPR and DAPS strains. Two specific
examples were components of the agr locus (as well as the down-
stream hld locus responsible for d-haemolysin production) and the
two-component regulatory system, saeRS. There were notable
trends towards down-regulation of these loci in the DAPR versus
DAPS strains. Consequently, differential expression of numerous
virulence factors that are either agr-regulated and/or saeRS-
regulated was also observed, i.e. spa, fnbA/B, hla and coa.54
qRT–PCR validation of microarray data for selected
genes: comparisons with other DAPS–DAPR strain pairs
As an independent, but complementary metric, we utilized qRT–
PCR to validate the relative expression levels of selected genes,
including several found to be differentially regulated by microar-
ray analysis. This list of genes was specifically prioritized by virtue
of known or expected effects on virulence,17,24 as well as their
potential for being part of an interactive regulatory network
involved in the DAPR phenotype [e.g. agr; mprF (fmtC)].24,55 As
previously established by a number of other studies, the absolute
magnitude of the normalized amplification signals reflected a
broader dynamic range in qRT–PCR as compared with microarray
measurements.32,56
Overall, the results of the qRT–PCR analyses (Table 4) paral-
leled the microarray determinations in terms of up- or down-
regulation, except for the down-regulated expression of yycI in
701. Importantly, qRT–PCR data confirmed the substantial
down-regulation of agr and hld expression in the principal DAPR
versus the DAPS strain pair, as also detected by microarray analy-
sis. Similarly, a significant increase in the expression of rot and
hla as well as sarT and saeRS was noted by qRT–PCR comparing
the DAPR versus DAPS strains, in agreement with the microarray
data. However, there was an apparent disconnection between
hla abundance when compared with agrA expression. In strain
701, the low level of agrA (activator of hla) and the high level
of rot (repressor of hla) transcripts would not normally be com-
patible with high hla transcription. This observation suggests
either a mutation/dysfunction in Rot and/or a mutation in the
promoter region of hla. Alternatively, the increased hla may be
explained by the increase in SaeRS, increased MgrA and
increased SarZ (data not shown). They all increase hla even in
the absence of RNAIII that acts upon Rot (Figure S2, available
as Supplementary data at JAC Online, shows some of the poten-
tial regulator interactions). Lastly, the levels of asp23, sarA and
mprF (fmtC) transcription were significantly elevated in compar-
ing the 616–701 DAPS versus DAPR isolates, while those for asp23
and sarA were only slightly increased in the DAPR strain.
We compared the qRT–PCR profiles of the prioritized genes of
interest above for our prototype strain pair (616–701) with those
of two other recent clinical DAPS–DAPR strain pairs (BOY755–
BOY300; and MRSA11-11–REF2145) (Table 4). Of note, the
Table 2. List of genes responsible for difference during complete
genome hybridization
Gene Present only in strain
arsB 701
ccrB 701
ileS 701
nes 701
qacR 701
repA 701
SA1763 701
SA1824 701
SACOL0332 701
SACOL0902 701
SACOL1582 701
SAUSA300_pUSA030027 701
SAUSA300_pUSA030030 701
SAUSA300_pUSA030034 701
SAUSA300_pUSA030035 701
SAUSA300_pUSA030036 701
tnpF 616
traA 701
traB 701
traC 701
traI 701
traJ 701
traK 701
traM 701
Fischer et al.
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Table 3. List of genes showing differential expression between daptomycin-susceptible and -non-susceptible isolates
Gene Function
Fold change 701 versus
wild-type (5 h)
COG functional
category
Transport and metabolism
arcA arginine deiminase 0.518 E
arcB ornithine carbamoyltransferase 0.456 E
arcB1 ornithine carbamoyltransferase 0.415 E
arcB2 ornithine carbamoyltransferase 0.552 E
arcD arginine/ornithine antiporter 2.037 E
arg arginase 0.466 E
argF ornithine carbamoyltransferase 0.448 E
argH argininosuccinate lyase 4.777 E
SACOL0408 glyoxalase family protein 2.032 E
SACOL1916 amino acid ABC transporter, permease/substrate-binding protein 10.621 E
SAV2440 similar to amino acid permease 2.057 E
lacA galactose-6-phosphate isomerase subunit LacA 12.630 G
lacB galactose-6-phosphate isomerase subunit LacB 11.730 G
lacD tagatose 1,6-diphosphate aldolase 10.539 G
lacE PTS system, lactose-specific IIBC component 7.762 G
lacF PTS system, lactose-specific IIA component 7.590
lacG 6-phospho-b-galactosidase 8.629
lldP2 l-lactate permease 2.052 C
manA mannose-6-phosphate isomerase 4.969 G
SA0208 maltose ABC transporter, permease protein 2.642 G
scrA PTS system lactose-specific IIBC component 7.931 G
tagG teichoic acid ABC transporter permease protein 1.625 G
treP phosphoenolpyruvate and trehalose-specific PTS enzyme II 18.050 G
treC a-amylase family protein 19.550
SAV0734 FecCD transport family protein 3.969 P
SAV2417 cation efflux family protein 4.536 P
MW0149 hypothetical protein 10.694 I
sirC putative siderophore transport system permease 9.215 P
fadB 3-hydroxyacyl-CoA dehydrogenase 4.310 I
Cell wall/membrane/envelope biogenesis
capB capsular polysaccharide biosynthesis protein CapB 1.788 D
capC capsular polysaccharide biosynthesis protein CapC 2.433 G
lytN cell wall hydrolase 3.915
lytH N-acetylmuramoyl-l-alanine amidase 2.139 M
pbp2 penicillin binding protein 2 1.528 M
pbp4 penicillin binding protein 4 1.841 M
sgtA transglycosylase domain protein 3.477 M
tagA teichoic acid ABC transporter permease protein 3.516 M
tagG teichoic acid ABC transporter permease protein 2.232
Defence mechanisms and virulence factors
SACOL2356 ABC transporter, ATP-binding protein 11.740 V
SAV0198 ABC transporter, ATP-binding protein 3.895 V
SAV2360 ABC transporter, permease protein 7.640 V
coa coagulase precursor 7.618
fnbB fibronectin binding protein B 23.575
SAV0812 similar to secreted von Willebrand factor-binding protein 7.469
SAV0945 secreted von Willebrand factor-binding protein 10.824 P
sdrC SdrC protein 1.645
seg enterotoxin SEG 5.043
sei enterotoxin SEI 5.427
Continued
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differential expression profiles for rot, sarS and yycF were quite
consistent across the three strain sets, although the net profiles
differed significantly among the other genes queried. These data
suggested a strong strain-dependent impact on the overall
specific genetic networks responsible for the ultimate DAPR phe-
notype. These findings are similar to distinct strain-to-strain
expression profiling analyses among diverse vancomycin-
intermediate S. aureus (VISA) strains of S. aureus.13,57,58
Table 3. Continued
Gene Function
Fold change 701 versus
wild-type (5 h)
COG functional
category
sem enterotoxin SEM 4.349
seo enterotoxin SEO 10.160
sep enterotoxin SEP 3.616
pls methicillin-resistant surface protein 10.950
clpL ATP-dependent Clp protease 0.610 O
hla a-haemolysin precursor 1.470
hlb b-haemolysin 6.584
hld d-haemolysin 0.243
hlgC g-haemolysin 2.087
Signal transduction mechanisms
agrA accessory gene regulator A 0.634 K
agrB accessory gene regulator B 0.625 O
agrD accessory gene regulator D 0.574
saeR DNA-binding response regulator SaeR 1.966 T
saeS sensor histidine kinase SaeS 1.856 T
vraR DNA-binding response regulator VraR 2.219 T
vraS sensor histidine kinase VraS 2.071 T
lytR autolysin response regulator protein 4.424 K
rot repressor of toxins Rot 1.793
sarT staphylococcal accessory regulator T 4.177 K
treR transcriptional regulator, GntR family 10.891 K
Uncharacterized
SACOL0739/SA0634 acetyltransferase, GNAT family 7.287 J
MW0047 hypothetical protein 3.014
MW0203/SACOL0206 hypothetical protein 5.728
MW0372 hypothetical protein 9.550
MW0638/SACOL0736/SA0631 acetyltransferase, GNAT family 5.764
SACOL0478/SA0393 superantigen-like protein 6.094
SACOL1656/SA1428 hypothetical protein 4.880
SAV0868 hypothetical protein 15.320
ywpF/SACOL2090/SA1900 ywpF protein 2.080
yycI/SACOL0022/SA0020 yycI protein 1.675 S
yycJ/SACOL0023/SA0021 metallo-b-lactamase yycJ protein 1.735 R
Various
SAV2513/SACOL2522/SA2301 DedA family protein 4.169 S
spsA/SACOL0968/SA0825 signal peptidase IA 3.539 U
SACOL0872/SA0755 OsmC/Ohr family protein 0.444 O
rnhC/SACOL1150/SA0987 ribonuclease HIII 5.306 L
COG (cluster of orthologous groups) categories are: C, energy production and conversion; D, cell division and chromosome partitioning; E, amino acid
transport and metabolism; G, carbohydrate transport and metabolism; I, lipid metabolism; J, translation, ribosomal structure and biogenesis; K,
transcription; L, DNA replication, recombination and repair; M, cell envelope biogenesis, outer membrane; O, post-translational modification,
protein turnover, chaperones; P, inorganic ion transport and metabolism; R, general function prediction; S, function unknown; T, signal
transduction mechanisms; U, secretion; V, defence mechanism; PTS, phosphotransferase system. Values ,1 correspond to downregulated genes.
Fischer et al.
1704
Quantitative proteomics analysis
Three independent replicates (PR1, PR2 and PR3) identified 771
individual proteins (Figure S3a, available as Supplementary
data at JAC Online) by combining all proteins identified at least
once (see Table S1, available as Supplementary data at JAC
Online). More than 30% of the identified proteins had more
than one predicted transmembrane segment; on average, four
to five peptides were identified per protein, confirming the
robustness of the quantitative results. To further enhance the
accuracy, relative quantification was performed on 546 proteins
commonly identified in at least two measurements. Overall, the
number of proteins identified in at least two replicates reached
.70%, also supporting the robustness of the analysis for the
most abundant proteins. Figure S3(b) (available as Supplemen-
tary data at JAC Online) shows the proportion of proteins in
each cluster of orthologous groups (COG) considering the anno-
tation of N315 genome and in our study. Both profiles appear
similar except for one category, ‘J’ (consisting of translation,
ribosomal structure and biogenesis), which covers the most
abundant bacterial proteins.
Following our conservative quantitative proteomic analysis,
only 27 proteins were found to be differentially produced
between the DAPR and DAPS strains (Table 5). Thus, comparison
of this relatively short list with the more extensive differential
microarray results failed to detect significant overlap, as is
often observed for such analysis.59,60 Moreover, a number of pro-
teins homologous to those involved in RNA turnover (degrado-
some) in Bacillus subtilis were overexpressed in strain 701,
offering a potential explanation for the above lack of overlap
between ‘omics’ techniques.61 Thus, Eno, RNaseJ1, RNAseJ2,
PfkA and Pnp exhibited 1.76-, 1.31-, 1.21-, 1.47- and 1.12-fold
increases in the DAPR strain (Table 5 and Table S1), likely increas-
ing RNA degradation.
After strategic categorization, the ascribed functions of genes
or proteins found to be differentially abundant were quite similar.
The main protein categories that overlapped with microarray
analyses represented target genes involved in membrane
metabolism (across all metabolic categories) as well as putative
virulence genes (PurH, PsaA, enolase or GapA), stress response
genes or genes involved in biofilm formation (MsmX, FabF,
enolase, PurH, SdhA-B or Asp23).41,62,63 Extensive query of the
SAMMD database (http://www.bioinformatics.org/sammd/)
found that the majority of the protein set (92%) showing differ-
ential abundance between our two principal strains has been
previously documented to be involved in stress response at
the transcriptional level.64–66 We also found that 13 of the
differentially produced proteins (48%) are involved in biofilm
regulation,67–69 such as SdhA-B. Additionally, an important
number of proteins appearing in this list (n¼12; 44%) are
involved in translation processes (COG J).
Discussion
S. aureus (especially MRSA) has been considered for decades as a
prototypic hospital-acquired pathogen. However, secular trends
have demonstrated that MRSA strains are now responsible for
many severe community-acquired infections.70,71 S. aureus has
a propensity to rapidly develop resistance to many antimicrobial
classes22,72–76 and this predominantly occurs by: (i) acquisition
of resistance determinants;77 (ii) phenotypic variation;78 or (iii)
profound alterations of its genetic repertoire.79 This latter cat-
egory is likely the most difficult to study, as it requires the deploy-
ment of extensive and parallel analytical methods (e.g. whole
transcriptomic and quantitative proteomic profiling) to uncover
discrete genome-scale modifications potentially involved in a
given resistance mechanism.13,14,16,80 In addition, only limited
correlations have been reported between a given gene transcript
level and the abundance of its respective encoded protein.59,60
With these issues in mind, our group has recently used several
robust analytical approaches to document differential protein
abundance between isogenic MRSA strains and their spon-
taneous glycopeptide-intermediate S. aureus (GISA) deriva-
tives.38 Moreover, we have used such strategies to identify
targets involved in cell wall biogenesis or in cell division that
were not decipherable by transcriptomic analysis.59,81 The
current study extends these approaches to analyse potential
genotypic and phenotypic mechanisms underlying the DAPR
phenotype.
The spontaneous emergence of S. aureus with decreased sus-
ceptibility to daptomycin can be rapidly obtained in vitro,82
suggesting an early adaptive mechanism(s) induced by exposure
to daptomycin. Cui et al.83 reported a correlation between
co-evolution of the DAPR and GISA phenotypes in S. aureus by
in vitro passage in daptomycin-containing environments,
suggesting that resistance to these two structurally distinct mol-
ecules was triggered by a common pathway(s). More recently,
the same group identified putative pathways associated with
DAPR using a transcriptomic approach, highlighting the potential
contribution of the vraSR two-component regulatory system in
this phenotype.17
Despite these interesting findings, fundamental insights
remain to be identified regarding potential genetic mechanisms
Table 4. Expression of selected genes in each DAPR from our three strain pairs, and comparison with quantitative transcriptomics and proteomics
RQ DAPR versus DAPS rot sarA sarS sarT hla agrA mprF (fmtC) asp23 hld sarR yycF yycI saeRS
BOY300 1.37* 0.92 1.28 0.78 1.00 1.28* 1.12 0.53 1.49* 1.00 0.79* 1.27* 1.66*
REF2145 1.29* 1.00 1.05 0.77 0.06* 0.58* 0.71* 0.94 0.86 1.04 0.66* 0.72* 0.24*
qRT–PCR 701 2.53* 1.09 1.84* 6.01* 1.82* 0.25* 1.47* 1.49 0.04* 0.74* 0.81* 0.79* 2.84*
Microarray results 1.90 — — 4.20 1.50 0.63 — — 0.24 — — 1.67 2.00
Proteomic results — 1.4 — — — — — 2.2* — — — — 1.00
*Statistically significant (t-test value ,0.01); RQ, relative quantity.
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of DAPR in strains that were directly isolated from
daptomycin-treated patients. Thus, in the current investi-
gation, we used one principal pair of isolates obtained from
a patient with endocarditis, in which the initially DAPS
strain (616) emerged with a DAPR phenotype (701) during
daptomycin treatment.22 Two additional pairs of isolates
showing similar evolution (also obtained from patients with
endocarditis), which evolved from DAPS parental strains
during daptomycin therapy, were used in qRT–PCR exper-
iments to evaluate whether or not putative regulatory
events leading to DAPR in S. aureus were strain-dependent
or more universal.
A number of pivotal and interesting findings emerged from
our complementary analytical strategies, which revealed specific
changes in gene expression or protein abundance between the
DAPR and DAPS isolates. Firstly, genomic analysis revealed the
presence of the plasmid pUSA300 in the principal DAPR strain,
but not in the DAPS parental strain. Of note, USA300 clinical iso-
lates, which carry this plasmid, are DAPS.36 Thus, the presence of
the pUSA300 plasmid does not appear to directly confer the
DAPR phenotype.
Secondly, extensive differences in the expression of several
central metabolic function genes were observed in the DAPS
versus DAPR strains, along with the differential expression of
Table 5. Proteins differentially expressed between 701 and 616
Fold change DAPR versus DAPS Description Common name Gene name
METABOLISM
energy production and conversion C
1.62 acetate kinase AckA SA1533
0.59 succinate dehydrogenase flavoprotein subunit SdhA SA0995
0.61 succinate dehydrogenase iron–sulphur protein subunit SdhB SA0996
carbohydrate transport and metabolism G
1.76 enolase (2-phosphoglycerate dehydratase) Eno SA0731
2.17 glyceraldehyde-3-phosphate dehydrogenase 1 GapA SA0727
0.36 maltose transmembrane transporter activity SA0207
0.44 multiple sugar-binding transport ATP-binding protein MsmX SA0206
amino acid transport and metabolism E
1.54 bifunctional purine biosynthesis protein PurH SA0925
lipid transport and metabolism I
2.10 3-oxoacyl-(acyl-carrier-protein) synthase 2 FabF SA0843
secondary metabolites biosynthesis, transport and catabolism Q
0.40 dehydrosqualene desaturase CrtN SA2348
inorganic ion transport and metabolism P
0.56 lipoprotein similar to streptococcal adhesin PsaA SA0587
INFORMATION STORAGE AND PROCESSING
translation, ribosomal structure and biogenesis J
1.80 30S ribosomal protein S10 RpsJ SA2048
1.81 30S ribosomal protein S13 RpsM SA2025
1.72 30S ribosomal protein S2 RpsB SA1099
2.52 30S ribosomal protein S3 RpsC SA2041
1.68 30S ribosomal protein S4 RpsD SAS052
1.71 30S ribosomal protein S5 RpsE SA2031
2.08 30S ribosomal protein S6 RpsF SA0352
1.88 30S ribosomal protein S7 RpsG SA0504
1.51 50S ribosomal protein L7/L12 RplL SA0498
1.63 elongation factor Tu (EF-Tu) TufA SA0506
1.56 lysyl-tRNA synthetase LysRS SA0475
1.71 prolyl-tRNA synthetase ProRS SA1106
CELLULAR PROCESS AND SIGNALLING
signal transduction mechanisms T
0.44 stress response protein SA1528
UNKNOWN
2.18 alkaline shock protein 23 Asp23 SA1984
1.64 GTP-sensing transcriptional pleiotropic repressor CodY SA1098
0.54 hypothetical protein SA0269
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numerous genes involved in important regulatory processes. For
example, the agr locus appears to be involved in the DAPR mech-
anism. Evidence for this interpretation comes from RNAIII and
hld transcripts showing moderate decreases, as corroborated
by reduced d-haemolysin production in two of the three DAPR
isolates queried (Figure S1). Simultaneously, we observed
increased saeRS expression in the DAPR strain, a finding also com-
patible with reduced agr function.84 Moreover, expression of
vraSR, a key two-component regulatory system involved in the
control of cell wall synthesis in S. aureus, was enhanced in the
DAPR strain. This latter profile has been previously identified in
GISA isolates14 and in strains exposed to daptomycin in vitro.85
We also noticed a slight increase of the asp23 transcript levels
and its real increase at the protein level in the DAPR; this locus
is a reliable surrogate marker for expression of the key global reg-
ulator, SigB.86 Collectively, these observations are consistent with
a recent report showing that daptomycin impacts genes involved
in both the cell wall stress stimulon and in membrane
depolarization.85
Thirdly, the notion that daptomycin can target the staphylo-
coccal cell wall as well as its CM was underscored in the evol-
ution towards DAPR. Thus, the abundance of differentially
expressed genes (as well as their translation products) involved
in the metabolism of the bacterial cell wall was notably distinct
between the principal strain pair. A number of such genes (e.g.
pbp2 and pbp4, lytN and lytH, tagA, and sgtA) have been pre-
viously reported to be differentially regulated in the following
conditions: stress response to cell wall-active antibiotics;87 mild
acidic shock;88 or during the stringent response.64 Likewise, our
recent findings of thickened cell walls in this same DAPR strain
(701) by TEM,25 as well as in an in vitro-selected DAPR strain
are also consistent with this paradigm.8,13 Current studies in
our laboratories are focused upon a detailed comparative evalu-
ation of the cell wall compositions of our DAPS–DAPR strain
pair.25
Fourthly, we employed qRT–PCR to confirm the differential
expression profiles of a number of critical S. aureus global regu-
lators and structural virulence genes that were disclosed in the
transcriptomic analyses. The specific genes assessed by qRT–
PCR were selected based on their putative roles in endovascular
infections (related to their individual or combined impacts upon
surface adhesins, exotoxins and/or exoproteins likely involved in
one or more pathogenetic phases of such infections).89 As in
the microarray analyses above, qRT–PCR analysis showed that
the expression of most of these genes was up-regulated in the
DAPR strain (701) as compared with the DAPS parental strain
(616), with the notable exceptions of down-regulation of sarR
and agr expression (as evidenced by reductions in both agrA
and hld expression levels). The finding of reduced agr expression
in the DAPR strain is of interest in the context of VISA strains.
Several studies have confirmed the relationship of agr deletions
or point mutations, reduced agr function phenotypically and gly-
copeptide resistance.15 Despite down-regulation of agr in strain
701, hla expression was significantly up-regulated in the face
of rot up-regulation. One logical explanation for this seemingly
paradoxical interactive network of gene expressions is the acqui-
sition of a loss-in-function mutation in rot;90,91 sequence analysis
of the rot locus is in progress.
In formulating potential DAPR interactive pathways, it seems
clear that there are strain-to-strain variations. For the 616–701
strain pair, in addition to increased rot and reduced agr in 701,
sarT (encoding for a negative regulators of hla) is also
up-regulated. Thus, increased hla production may be explained
by the increase in saeRS, increased mgrA and increased sarZ
expression (our microarray results showed a trend towards
increased expression in 701). Indeed they will all increase hla
even in the absence of RNAIII acting upon Rot. Hence, we
propose that 701 shows increased hla even in the presence of
Rot and SarT repressor functionalities, i.e. it is either autonomous
or SaeRS, MgrA and SarZ are stimulating increased hla tran-
scripts.51 In the 11-11/REF2145 strain pair, reduced hla transcript
levels in REF2145 are associated with reduced agr expression and
increased rot transcription. However, in BOY300, hla transcripts
are decreased despite the increase in agr, hld and saeRS,
without any increase in rot transcripts, suggesting that the pro-
duction of hla has become autonomous. Finally, in terms of
mprF (fmtC) expression involved in saeRS regulation,92 this
tends to vary from strain to strain, ranging from unchanged
(BOY300), to increased (701), to reduced (REF2145). It has
been well chronicled that in daptomycin-resistant staphylococci,
mutations in the mprF gene usually produce gains in func-
tion.22,24 Thus, it is quite possible that strains BOY300 and
REF2145 have reduced transcript levels, but increased activity
of MprF due to gain-in-function mutations (regulator interactions
are summarized in Figure S2).
Our studies above support a hypothesis that the DAPR pheno-
type results from coordination among multiple adaptive
response circuits. For example, our observed reduction in sarR
expression in the DAPR isolate can be linked to an increase in
sarA expression. In turn, an increase in sarA expression could
modify biofilm formation as well as increase hla expression via
an agr-independent pathway.93 Supporting this concept, the
current studies demonstrated a clear difference in biofilm
dynamics and phenotype in the DAPS versus DAPR strains.
Finally, a pivotal observation in our investigation was that the
key regulatory locus, yycFGHI, was differentially expressed when
our DAPS and DAPR strain sets were compared. This operon is a
key regulator affecting CM lipid homeostasis, cell wall metab-
olism and biofilm formation.19,53,94,95 The expression of this reg-
ulator contributes to modification of the net surface charge via
both mprF and dlt pathways; thus, likely impacting daptomycin
binding as well as the initial attachment phases in biofilm for-
mation.19 These latter interpretations are substantiated by our
findings that our principal study strain pair (616–701) differed
in their capacity to form biofilm in the presence of the antimicro-
bial lipid, oleic acid. Oleic acid has been reported previously as a
microbicidal agent against S. aureus, presumably through a
mechanism involving membrane fluidity and the lipid compo-
sition of the cytoplasmic membrane.9 We used oleic acid
instead of daptomycin, because: (i) they share similarities in
their lipid tail (7–8 CH2 following a CH3); and (ii) we were able
to use similar concentrations of this compound for both
strains. Moreover, another chemical compound called friulimicin
B that shares similar structure and chemical properties with dap-
tomycin also possesses a lipid tail of 8 CH2 (+2 CH3 terminus)
before a C¼C double bond, like the oleic acid lipid tail.96 Impor-
tantly, like daptomycin, friulimicin B absolutely requires Ca2+
for antimicrobial activity. In the present study, the DAPR isolate
retained the ability to produce an abundant and structurally dis-
tinct biofilm, with greater adhesive properties, even in the setting
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of an antibacterial lipid environment (i.e. oleic acid exposure). It
is tempting to speculate that an adaptation to the lipid moiety of
daptomycin in DAPR strains may be involved in the relative resist-
ance of this strain to oleic acid, especially within biofilms. If so,
this modification of biofilm formation could be linked to an
increase in sarA expression in the DAPR strain. For example,
Weiss et al.97 showed an increased susceptibility to daptomycin
linked to a decreased biofilm adherence (in vivo) in an S. aureus
sarA mutant.
Examination of our composite data sets from our principal
strain pair suggested that changes in YycF and YycI could
account for many of the changes found in the DAPR strain.
Increased positive surface charge (e.g. via gain-in-function
mutations in mprF) and increased membrane fluidity have
been associated with DAPR.18 In addition, some DAPR strains
show thickened cell walls and altered biofilm formation. Acti-
vated YycF positively regulates genes involved in cell division,
and ultimately cell wall thickness and division planes. Thus, a
reduction in YycF activity due to either increased YycI activity
(an inhibitor of YycF) or to a mutation in yycF could account for
alterations in the cell wall structure. When yycI transcripts are
increased, then YycFG will have reduced activity (i.e. strain
BOY300). When yycF is reduced, then there is no need to have
higher levels of yycI, as either high yycI or low yycF will result
in the same phenotype. This implies that more than one
mutation can provide the same phenotype, i.e. reduced
YycFP. Moreover, YycF regulates mprF, as well as MgrA, which
is the sole regulator of sarZ and a repressor of sarS and sarT,98
which are differentially regulated in our three backgrounds
(Table 4 and Figure S2). MgrA represses icaABDC, which is essen-
tial for biofilm formation. Thus, reduced activation of mgrA due
to decreased YycF activity could result in increased biofilm for-
mation. Lastly, activated YycF is a positive regulator of PhoP,
which negatively regulates the tagA operon. As TagA is the first
committed step in the lipoteichoic acid (LTA) pathway, a
reduction in YycF activity would reduce the repressive effect of
PhoP, thereby leading to more LTA. LTA inhibits the autolysin
(Alt) and increases the positive charge on the cell wall, thereby
influencing both cell wall thickness and daptomycin suscepti-
bility, respectively.8 These interactive paradigms are summarized
in a putative network model that allows integration of biofilm
formation, changes in positive surface charge, cell wall structure,
daptomycin binding and cell wall susceptibility to lipids (Figure 3).
We view this model as a working hypothesis upon which future
experiments can be performed in the examination of DAPR.
Another explanation for the daptomycin-resistant phenotype
would be that there are multiple mutations in distinct regulatory
pathways in such strains. This hypothesis is compatible with the
stepwise development of resistance that is found both in
patients receiving long-term daptomycin, as well as in strains
undergoing serial in vitro passage in daptomycin in the labora-
tory (Figure S2). Clearly, not all our data sets fit into a single
cohesive model; this observation is entirely consistent with the
stepwise development of DAPR, as well as a summation of mul-
tiple mutations producing this resistance phenotype.
It should be emphasized that in comparing qRT–PCR data
sets between our three DAPS–DAPR strain pairs, there were
several consistent observations in the DAPR strains; up-regulation
of rot and sarS, and down-regulation of yycF. However,
expression patterns of the other 10 genes queried in our
focused analysis yielded no universally consistent profile. This
finding would underscore the concepts that: (i) DAPR networks
are complex and strain specific; and (ii) the accumulation of
diverse mutations during daptomycin exposures, as confirmed
for many reported DAPR strains,22 may well be critical in ultimate
DAPR ‘pathways’.
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Figure 3. Potential pathways leading to DAPR. Cell wall metabolism and regulators appear as major targets of mechanisms leading to DAPR acquired
in vivo during therapy. The biosynthesis of bacterial envelopes is involved in the process leading to major phenotypic changes between DAPS and DAPR
S. aureus. Black bars represent inhibition.
Fischer et al.
1708
Conclusions
In vivo emergence of DAPR in S. aureus during daptomycin treat-
ment is the result of multiple adaptations in metabolic functions,
global regulatory pathways, as well as the biogenesis of the cellu-
lar envelope. The evolution of DAPR in the clinical strain set 616–
701 corresponded with an increase in the DAPR strain’s capability
to generate a pronounced and structurally distinct biofilm, and to
resist toxic membrane-targeting antimicrobial lipids. Combined
transcriptomic and proteomic analyses provided a global view of
the complex process corresponding to the adaptive DAPR pheno-
type. Several genes and proteins, potentially involved in the emer-
gence of DAPR in vivo, were identified in this study, and appear
quite distinct from in vitro-selected DAPR organisms. Finally, com-
parison between three genotypically distinct strain pairs revealed
a strain-dependent, multifactorial regulation in the DAPR pheno-
type. It appears likely that the global regulatory locus, yycFGHI,
plays a key role in the development of DAPR.
Acknowledgements
We thank Dr Ambrose Cheung (Dartmouth Medical College, Hanover, NH,
USA) for assistance in the genotypic interpretations and Dr Andreas
Peschel (University of Tubingen, Germany) for many helpful discussions.
Funding
This research was supported by grants from the NIH to A. S. B.
(AI-039108) and M. R. Y. (AI-039001), grants 3100A0-112370/1 (to
J. S.) and 3100A0-116075 (to P. F.) from the Swiss National Science
Foundation.
Transparency declarations
None to declare.
Supplementary data
Figures S1–S3 and Table S1 are available Supplementary data at JAC
Online (http://jac.oxfordjournals.org/).
References
1 Mortara LA, Bayer AS. Staphylococcus aureus bacteremia and
endocarditis. New diagnostic and therapeutic concepts. Infect Dis Clin
North Am 1993; 7: 53–68.
2 Hobbs JK, Miller K, O’Neill AJ et al. Consequences of
daptomycin-mediated membrane damage in Staphylococcus aureus. J
Antimicrob Chemother 2008; 62: 1003–8.
3 Sakoulas G, Eliopoulos GM, Alder J et al. Efficacy of daptomycin in
experimental endocarditis due to methicillin-resistant Staphylococcus
aureus. Antimicrob Agents Chemother 2003; 47: 1714–8.
4 Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004; 364: 369–79.
5 Eliopoulos GM, Thauvin C, Gerson B et al. In vitro activity and
mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.
Antimicrob Agents Chemother 1985; 27: 357–62.
6 Gu JQ, Nguyen KT, Gandhi C et al. Structural characterization of
daptomycin analogues A21978C1-3(d-Asn11) produced by a recombinant
Streptomyces roseosporus strain. J Nat Prod 2007; 70: 233–40.
7 Lakey JH, Ptak M. Fluorescence indicates a calcium-dependent
interaction between the lipopeptide antibiotic LY146032 and
phospholipid membranes. Biochemistry 1988; 27: 4639–45.
8 Mishra NN, Yang SJ, Sawa A et al. Analysis of cell membrane
characteristics of in vitro-selected daptomycin-resistant strains of
methicillin-resistant Staphylococcus aureus. Antimicrob Agents
Chemother 2009; 53: 2312–8.
9 Chamberlain NR, Mehrtens BG, Xiong Z et al. Correlation of carotenoid
production, decreased membrane fluidity, and resistance to oleic acid
killing in Staphylococcus aureus 18Z. Infect Immun 1991; 59: 4332–7.
10 Campbell IM, Crozier DN, Pawagi AB. Effect of hypobaric oxygen and
oleic acid on respiration of Staphylococcus aureus. Eur J Clin Microbiol
1986; 5: 622–8.
11 Stenz L, Francois P, Fischer A et al. Impact of oleic acid
(cis-9-octadecenoic acid) on bacterial viability and biofilm production in
Staphylococcus aureus. FEMS Microbiol Lett 2008; 287: 149–55.
12 Gotz F. Staphylococcus and biofilms. Mol Microbiol 2002; 43:
1367–78.
13 Cui L, Ma X, Sato K et al. Cell wall thickening is a common feature of
vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 2003;
41: 5–14.
14 Kuroda M, Kuroda H, Oshima T et al. Two-component system VraSR
positively modulates the regulation of cell-wall biosynthesis pathway in
Staphylococcus aureus. Mol Microbiol 2003; 49: 807–21.
15 Sakoulas G, Eliopoulos GM, Moellering RC Jr et al. Accessory gene
regulator (agr) locus in geographically diverse Staphylococcus aureus
isolates with reduced susceptibility to vancomycin. Antimicrob Agents
Chemother 2002; 46: 1492–502.
16 Koehl JL, Muthaiyan A, Jayaswal RK et al. Cell wall composition and
decreased autolytic activity and lysostaphin susceptibility of
glycopeptide-intermediate Staphylococcus aureus. Antimicrob Agents
Chemother 2004; 48: 3749–57.
17 Camargo IL, Neoh HM, Cui L et al. Serial daptomycin selection
generates daptomycin-nonsusceptible Staphylococcus aureus strains
with a heterogeneous vancomycin-intermediate phenotype. Antimicrob
Agents Chemother 2008; 52: 4289–99.
18 Martin PK, Li T, Sun D et al. Role in cell permeability of an essential
two-component system in Staphylococcus aureus. J Bacteriol 1999;
181: 3666–73.
19 Dubrac S, Boneca IG, Poupel O et al. New insights into the WalK/WalR
(YycG/YycF) essential signal transduction pathway reveal a major role in
controlling cell wall metabolism and biofilm formation in
Staphylococcus aureus. J Bacteriol 2007; 189: 8257–69.
20 Mwangi MM, Wu SW, Zhou Y et al. Tracking the in vivo evolution of
multidrug resistance in Staphylococcus aureus by whole-genome
sequencing. Proc Natl Acad Sci USA 2007; 104: 9451–6.
21 Ohta T, Hirakawa H, Morikawa K et al. Nucleotide substitutions in
Staphylococcus aureus strains, Mu50, Mu3, and N315. DNA Res 2004;
11: 51–6.
22 Jones T, Yeaman MR, Sakoulas G et al. Failures in clinical treatment of
Staphylococcus aureus infection with daptomycin are associated with
alterations in surface charge, membrane phospholipid asymmetry, and
drug binding. Antimicrob Agents Chemother 2008; 52: 269–78.
23 Ernst CM, Staubitz P, Mishra NN et al. The bacterial defensin resistance
protein MprF consists of separable domains for lipid lysinylation and
antimicrobial peptide repulsion. PLoS Pathog 2009; 5: e1000660.
24 Yang SJ, Xiong YQ, Dunman PM et al. Regulation of mprF in
daptomycin-nonsusceptible Staphylococcus aureus strains. Antimicrob
Agents Chemother 2009; 53: 2636–7.
‘Omics’ profiling in daptomycin-non-susceptible Staphylococcus aureus
1709
JAC
25 Yang SJ, Nast CC, Mishra NN et al. Cell wall thickening is not a
universal accompaniment of the daptomycin nonsusceptibility
phenotype in Staphylococcus aureus: evidence for multiple resistance
mechanisms. Antimicrob Agents Chemother 2010; 54: 3079–85.
26 Yang SJ, Kreiswirth BN, Sakoulas G et al. Enhanced expression of
dltABCD is associated with the development of daptomycin
nonsusceptibility in a clinical endocarditis isolate of Staphylococcus
aureus. J Infect Dis 2009; 200: 1916–20.
27 Murthy MH, Olson ME, Wickert RW et al. Daptomycin non-susceptible
meticillin-resistant Staphylococcus aureus USA 300 isolate. J Med
Microbiol 2008; 57: 1036–8.
28 Traber K, Novick R. A slipped-mispairing mutation in AgrA of
laboratory strains and clinical isolates results in delayed activation of
agr and failure to translate d- and a-haemolysins. Mol Microbiol 2006;
59: 1519–30.
29 McCalla C, Smyth DS, Robinson DA et al. Microbiological and genotypic
analysis of methicillin-resistant Staphylococcus aureus bacteremia.
Antimicrob Agents Chemother 2008; 52: 3441–3.
30 Francois P, Huyghe A, Charbonnier Y et al. Use of an automated
multiple-locus, variable-number tandem repeat-based method for rapid
and high-throughput genotyping of Staphylococcus aureus isolates. J
Clin Microbiol 2005; 43: 3346–55.
31 Francois P, Harbarth S, Huyghe A et al. Methicillin-resistant
Staphylococcus aureus, Geneva, Switzerland, 1993–2005. Emerg Infect
Dis 2008; 14: 304–7.
32 Charbonnier Y, Gettler BM, Francois P et al. A generic approach for the
design of whole-genome oligoarrays, validated for genomotyping,
deletion mapping and gene expression analysis on Staphylococcus
aureus. BMC Genomics 2005; 6: 95.
33 Kuroda M, Ohta T, Uchiyama I et al. Whole genome sequencing of
meticillin-resistant Staphylococcus aureus. Lancet 2001; 357: 1225–40.
34 Baba T, Takeuchi F, Kuroda M et al. Genome and virulence
determinants of high virulence community-acquired MRSA. Lancet
2002; 359: 1819–27.
35 Gill SR, Fouts DE, Archer GL et al. Insights on evolution of virulence and
resistance from the complete genome analysis of an early
methicillin-resistant Staphylococcus aureus strain and a
biofilm-producing methicillin-resistant Staphylococcus epidermidis
strain. J Bacteriol 2005; 187: 2426–38.
36 Diep BA, Gill SR, Chang RF et al. Complete genome sequence of
USA300, an epidemic clone of community-acquired meticillin-resistant
Staphylococcus aureus. Lancet 2006; 367: 731–9.
37 Holden MT, Feil EJ, Lindsay JA et al. Complete genomes of two clinical
Staphylococcus aureus strains: evidence for the rapid evolution of
virulence and drug resistance. Proc Natl Acad Sci USA 2004; 101:
9786–91.
38 Scherl A, Francois P, Charbonnier Y et al. Exploring glycopeptide
resistance in Staphylococcus aureus: a combined proteomics and
transcriptomics approach for the identification of resistance related
markers. BMC Genomics 2006; 7: 296.
39 Talaat AM, Howard ST, Hale W et al. Genomic DNA standards for gene
expression profiling in Mycobacterium tuberculosis. Nucleic Acids Res
2002; 30: e104.
40 Garzoni C, Francois P, Huyghe A et al. A global view of Staphylococcus
aureus whole genome expression upon internalization in human
epithelial cells. BMC Genomics 2007; 8: 171.
41 Renzoni A, Francois P, Li D et al. Modulation of fibronectin adhesins
and other virulence factors in a teicoplanin-resistant derivative of
methicillin-resistant Staphylococcus aureus. Antimicrob Agents
Chemother 2004; 48: 2958–65.
42 Vaezzadeh AR, Simicevic J, Chauvet A et al. Imaging mass
spectrometry using peptide isoelectric focusing. Rapid Commun Mass
Spectrom 2008; 22: 2667–76.
43 Elias JE, Gygi SP. Target–decoy search strategy for increased
confidence in large-scale protein identifications by mass spectrometry.
Nat Methods 2007; 4: 207–14.
44 Dayon L, Hainard A, Licker V et al. Relative quantification of proteins in
human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Anal
Chem 2008; 80: 2921–31.
45 Shadforth IP, Dunkley TP, Lilley KS et al. i-Tracker: for quantitative
proteomics using iTRAQ. BMC Genomics 2005; 6: 145.
46 Kim CC, Joyce EA, Chan K et al. Improved analytical methods for
microarray-based genome-composition analysis. Genome Biol 2002; 3:
0065.1–0065.17.
47 Dunman PM, Murphy E, Hanney S et al. Transcription profiling-based
identification of Staphylococcus aureus genes regulated by the agr and/
or sarA loci. J Bacteriol 2001; 183: 7341–53.
48 Pantrangi M, Singh VK, Wolz C et al. Staphylococcal superantigen-like
genes, ssl5 and ssl8, are positively regulated by Sae and negatively by Agr
in the Newman strain. FEMS Microbiol Lett 2010; 308: 175–84.
49 Beenken KE, Mrak LN, Griffin LM et al. Epistatic relationships between
sarA and agr in Staphylococcus aureus biofilm formation. PLoS One 2010;
5: e10790.
50 Majerczyk CD, Dunman PM, Luong TT et al. Direct targets of CodY in
Staphylococcus aureus. J Bacteriol 2010; 192: 2861–77.
51 Tamber S, Cheung AL. SarZ promotes the expression of virulence
factors and represses biofilm formation by modulating SarA and agr in
Staphylococcus aureus. Infect Immun 2009; 77: 419–28.
52 Quinn B, Hussain S, Malik M et al. Daptomycin inoculum effects and
mutant prevention concentration with Staphylococcus aureus. J
Antimicrob Chemother 2007; 60: 1380–3.
53 Friedman L, Alder JD, Silverman JA. Genetic changes that correlate
with reduced susceptibility to daptomycin in Staphylococcus aureus.
Antimicrob Agents Chemother 2006; 50: 2137–45.
54 Cheung AL, Bayer AS, Zhang G et al. Regulation of virulence
determinants in vitro and in vivo in Staphylococcus aureus. FEMS
Immunol Med Microbiol 2004; 40: 1–9.
55 Sakoulas G, Eliopoulos GM, Fowler VG Jr et al. Reduced susceptibility of
Staphylococcus aureus to vancomycin and platelet microbicidal protein
correlates with defective autolysis and loss of accessory gene regulator
(agr) function. Antimicrob Agents Chemother 2005; 49: 2687–92.
56 Ramakrishnan R, Dorris D, Lublinsky A et al. An assessment of
Motorola CodeLink microarray performance for gene expression
profiling applications. Nucleic Acids Res 2002; 30: e30.
57 Wootton M, MacGowan AP, Walsh TR. Expression of tcaA and mprF
and glycopeptide resistance in clinical glycopeptide-intermediate
Staphylococcus aureus (GISA) and heteroGISA strains. Biochim Biophys
Acta 2005; 1726: 326–7.
58 Wootton M, Bennett PM, MacGowan AP et al. Strain-specific
expression levels of pbp4 exist in isolates of glycopeptide-intermediate
Staphylococcus aureus (GISA) and heterogeneous GISA. Antimicrob
Agents Chemother 2005; 49: 3598–9.
59 Scherl A, Francois P, Bento M et al. Correlation of proteomic and
transcriptomic profiles of Staphylococcus aureus during the
post-exponential phase of growth. J Microbiol Methods 2005; 60: 247–57.
60 Corbin RW, Paliy O, Yang F et al. Toward a protein profile of Escherichia
coli: comparison to its transcription profile. Proc Natl Acad Sci USA 2003;
100: 9232–7.
61 Lehnik-Habrink M, Pfortner H, Rempeters L et al. The RNA
degradosome in Bacillus subtilis: identification of CshA as the major
Fischer et al.
1710
RNA helicase in the multiprotein complex. Mol Microbiol 2010;
doi:10.1111/j.1365-2958.2010.07264.x.
62 Conlon KM, Humphreys H, O’Gara JP. Inactivations of rsbU and sarA by
IS256 represent novel mechanisms of biofilm phenotypic variation in
Staphylococcus epidermidis. J Bacteriol 2004; 186: 6208–19.
63 Goerke C, Esser S, Kummel M et al. Staphylococcus aureus strain
designation by agr and cap polymorphism typing and delineation of agr
diversification by sequence analysis. Int J Med Microbiol 2005; 295:
67–75.
64 Anderson KL, Roberts C, Disz T et al. Characterization of the
Staphylococcus aureus heat shock, cold shock, stringent, and SOS
responses and their effects on log-phase mRNA turnover. J Bacteriol
2006; 188: 6739–56.
65 Schlag S, Nerz C, Birkenstock TA et al. Inhibition of staphylococcal
biofilm formation by nitrite. J Bacteriol 2007; 189: 7911–9.
66 Richardson AR, Dunman PM, Fang FC. The nitrosative stress response
of Staphylococcus aureus is required for resistance to innate immunity.
Mol Microbiol 2006; 61: 927–39.
67 Brady RA, Leid JG, Camper AK et al. Identification of Staphylococcus
aureus proteins recognized by the antibody-mediated immune
response to a biofilm infection. Infect Immun 2006; 74: 3415–26.
68 Beenken KE, Dunman PM, McAleese F et al. Global gene expression in
Staphylococcus aureus biofilms. J Bacteriol 2004; 186: 4665–84.
69 Resch A, Rosenstein R, Nerz C et al. Differential gene expression
profiling of Staphylococcus aureus cultivated under biofilm and
planktonic conditions. Appl Environ Microbiol 2005; 71: 2663–76.
70 Chambers HF. The changing epidemiology of Staphylococcus aureus?
Emerg Infect Dis 2001; 7: 178–82.
71 Charlebois ED, Perdreau-Remington F, Kreiswirth B et al. Origins of
community strains of methicillin-resistant Staphylococcus aureus. Clin
Infect Dis 2004; 39: 47–54.
72 Barber M. Methicillin-resistant staphylococci. J Clin Pathol 1961; 14:
385–93.
73 Chang S, Sievert DM, Hageman JC et al. Infection with
vancomycin-resistant Staphylococcus aureus containing the vanA
resistance gene. N Engl J Med 2003; 348: 1342–7.
74 Hiramatsu K, Okuma K, Ma XX et al. New trends in Staphylococcus
aureus infections: glycopeptide resistance in hospital and methicillin
resistance in the community. Curr Opin Infect Dis 2002; 15: 407–13.
75 Cambau E, Gutmann L. Mechanisms of resistance to quinolones.
Drugs 1993; 45 Suppl 3: 15–23.
76 Tsiodras S, Gold HS, Sakoulas G et al. Linezolid resistance in a clinical
isolate of Staphylococcus aureus. Lancet 2001; 358: 207–8.
77 Ryffel C, Kayser FH, Berger-Bachi B. Correlation between regulation of
mecA transcription and expression of methicillin resistance in
staphylococci. Antimicrob Agents Chemother 1992; 36: 25–31.
78 Proctor RA, Kahl B, von Eiff C et al. Staphylococcal small colony
variants have novel mechanisms for antibiotic resistance. Clin Infect Dis
1998; 27 Suppl 1: S68–74.
79 Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new
model of antibiotic resistance. Lancet Infect Dis 2001; 1: 147–55.
80 Boyle-Vavra S, Carey RB, Daum RS. Development of vancomycin and
lysostaphin resistance in a methicillin-resistant Staphylococcus aureus
isolate. J Antimicrob Chemother 2001; 48: 617–25.
81 Cui L, Lian JQ, Neoh HM et al. DNA microarray-based identification of
genes associated with glycopeptide resistance in Staphylococcus aureus.
Antimicrob Agents Chemother 2005; 49: 3404–13.
82 Liebowitz LD, Saunders J, Chalkley LJ et al. In vitro selection of
bacteria resistant to LY146032, a new cyclic lipopeptide. Antimicrob
Agents Chemother 1988; 32: 24–6.
83 Cui L, Tominaga E, Neoh HM et al. Correlation between reduced
daptomycin susceptibility and vancomycin resistance in
vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents
Chemother 2006; 50: 1079–82.
84 Rose WE, Rybak MJ, Tsuji BT et al. Correlation of vancomycin and
daptomycin susceptibility in Staphylococcus aureus in reference to
accessory gene regulator (agr) polymorphism and function.
J Antimicrob Chemother 2007; 59: 1190–3.
85 Muthaiyan A, Silverman JA, Jayaswal RK et al. Transcriptional profiling
reveals that daptomycin induces the Staphylococcus aureus cell wall
stress stimulon and genes responsive to membrane depolarization.
Antimicrob Agents Chemother 2008; 52: 980–90.
86 Mongodin E, Finan J, Climo MW et al. Microarray transcription analysis
of clinical Staphylococcus aureus isolates resistant to vancomycin.
J Bacteriol 2003; 185: 4638–43.
87 Utaida S, Dunman PM, Macapagal D et al. Genome-wide
transcriptional profiling of the response of Staphylococcus aureus to
cell-wall-active antibiotics reveals a cell-wall-stress stimulon.
Microbiology 2003; 149: 2719–32.
88 Weinrick B, Dunman PM, McAleese F et al. Effect of mild acid on gene
expression in Staphylococcus aureus. J Bacteriol 2004; 186: 8407–23.
89 Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:
520–32.
90 Geisinger E, Adhikari RP, Jin R et al. Inhibition of rot translation
by RNAIII, a key feature of agr function. Mol Microbiol 2006; 61: 1038–48.
91 Goerke C, Fluckiger U, Steinhuber A et al. Impact of the regulatory loci
agr, sarA and sae of Staphylococcus aureus on the induction of a-toxin
during device-related infection resolved by direct quantitative transcript
analysis. Mol Microbiol 2001; 40: 1439–47.
92 Sievers S, Ernst CM, Geiger T et al. Changing the phospholipid
composition of Staphylococcus aureus causes distinct changes in
membrane proteome and membrane-sensory regulators. Proteomics
2010; 10: 1685–93.
93 Chien Y, Manna AC, Projan SJ et al. SarA, a global regulator of
virulence determinants in Staphylococcus aureus, binds to a conserved
motif essential for sar-dependent gene regulation. J Biol Chem 1999;
274: 37169–76.
94 Dubrac S, Msadek T. Identification of genes controlled by the essential
YycG/YycF two-component system of Staphylococcus aureus. J Bacteriol
2004; 186: 1175–81.
95 Szurmant H, White RA, Hoch JA. Sensor complexes regulating
two-component signal transduction. Curr Opin Struct Biol 2007; 17:
706–15.
96 Schneider T, Gries K, Josten M et al. The lipopeptide antibiotic
friulimicin B inhibits cell wall biosynthesis through complex formation
with bactoprenol phosphate. Antimicrob Agents Chemother 2009; 53:
1610–8.
97 Weiss EC, Zielinska A, Beenken KE et al. Impact of sarA on daptomycin
susceptibility of Staphylococcus aureus biofilms in vivo. Antimicrob Agents
Chemother 2009; 53: 4096–102.
98 Ballal A, Ray B, Manna AC. sarZ, a sarA family gene, is transcriptionally
activated by MgrA and is involved in the regulation of genes
encoding exoproteins in Staphylococcus aureus. J Bacteriol 2009; 191:
1656–65.
‘Omics’ profiling in daptomycin-non-susceptible Staphylococcus aureus
1711
JAC
